ProGenTech to Develop Diagnostics with China’s CDC

Published: Dec 22, 2008

ChinaBio Today -- ProGenTech, a molecular diagnostics company headquartered in California but with its operations in Shanghai, signed a collaboration agreement with the China’s Center for Disease Control and Prevention (China CDC) to create a joint laboratory. The lab will focus on developing next generation molecular diagnostic systems and assays, using ProGenTech’s Entura instrument platform.

Back to news